The Quantellect read.As of Nov 19, 2026, 3 active firms cover Select Medical Holdings: 0 rate it Buy or better, 3 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $16.50 to $16.50, so the covering firms are broadly aligned. The average target of $16.50 sits 16% below the current $19.54. The rating mix has stayed broadly stable, with Buy-side ratings easing from 1 to 0 over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Neutral
Strong Buy00%
Buy00%
Neutral3100%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$16.50
-15.6% downside
Average target across 2 active firms as of Nov 19, 2026 vs $19.54 current
Highest Target$16.50
Average Target$16.50
Lowest Target$16.50
Detailed analyst forecasts for SEM
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 0 of 3 active firms rate SEM a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
Top analysts covering Select Medical Holdings
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SEM.
#1
BS
Bill Sutherland
Benchmark · Rank #48
Neutral
No targeton SEM
Overall win rate
46%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #150
Neutral
$16.50-15.6% to target
Overall win rate
44%
+ Follow
#3
AR
A.J. Rice
UBS · Rank #365
Neutral
$14.00-28.4% to target
Overall win rate
35%
+ Follow
#4
Joanna Gajuk
B of A Securities
Buy
$17.00-13.0% to target
Coverage
—
+ Follow
#5
Ann Hynes
Mizuho
Neutral
$16.50-15.6% to target
Coverage
—
+ Follow
SEM stock forecast FAQ
What is SEM's average 12-month price target?+
The 2 active firms with a live target average $16.50 for Select Medical Holdings over the next 12 months, ranging from a $16.50 high to a $16.50 low, as of Nov 19, 2026.
Is SEM stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 3 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 3 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover SEM?+
3 active firms have a recognized rating on Select Medical Holdings as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering SEM?+
Among analysts who currently cover SEM, Bill Sutherland of Benchmark has the strongest overall Quantellect track record (Rank #48). Their current call is Neutral.
Have analysts been upgrading or downgrading SEM lately?+
As of Nov 19, 2026, 0 of 3 active firms rate SEM a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SEM calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.